GO:0120561 phosphatidylinositol lysophospholipase A1 activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120561 phosphatidylinositol lysophospholipase A1 activity catalyzes the hydrolysis of 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) to sn-glycero-3-phospho-1D-myo-inositol, a fatty acid, and H+.
• This activity is a type of phospholipase A1 that specifically acts on phosphatidylinositol, distinguishing it from other lysophospholipases.
• It regulates lysophosphatidylinositol (LPI) levels, which are implicated in cancer progression, inflammation, and neurological disorders [2,3,7].
• Key enzymes with this activity include phospholipase B (PLB1) in yeast and the 85-kDa phospholipase A2 in macrophages, which also exhibits lysophospholipase activity [4,6].
• Dysregulation of this activity contributes to malignant melanoma, tumor angiogenesis, metastasis, and chemo-resistance through lipid signaling pathways [2,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the causal roles of genes encoding this activity in disease [1,5].
Description
Phosphatidylinositol lysophospholipase A1 activity (GO:0120561) is a molecular function that removes a fatty acid from phosphatidylinositol, generating lysophosphatidylinositol and a free fatty acid. This reaction is part of the broader phospholipase A1 family, which hydrolyzes the sn-1 acyl chain of phospholipids. The activity is critical for maintaining lipid homeostasis and producing bioactive lipid mediators that influence cell signaling, inflammation, and cancer progression [2,3]. Researchers study this activity to understand how cells regulate membrane composition and how dysregulation leads to diseases such as melanoma and inflammatory disorders [2,7]. The enzyme(s) responsible often exhibit dual phospholipase A1 and lysophospholipase activities, as seen in the yeast PLB1 protein and the 85-kDa phospholipase A2 in macrophages [4,6]. Understanding GO:0120561 provides a foundation for targeting lipid signaling pathways in therapeutic development.
phosphatidylinositol lysophospholipase A1 activity At A Glance
| GO ID | GO:0120561 |
|---|---|
| GO term | phosphatidylinositol lysophospholipase A1 activity |
| Ontology | molecular_function |
| Synonym | phosphatidylinositol lysophospholipase A1-type activity |
| Major function | Catalyzes the hydrolysis of phosphatidylinositol to lysophosphatidylinositol and a fatty acid |
| Reaction | 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = sn-glycero-3-phospho-1D-myo-inositol + a fatty acid + H+ |
| Substrate | 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) |
| Products | sn-glycero-3-phospho-1D-myo-inositol, a fatty acid, H+ |
| Enzyme class | Phospholipase A1 / lysophospholipase |
What Is GO:0120561?
GO:0120561 phosphatidylinositol lysophospholipase A1 activity is defined as the catalysis of the reaction: a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = sn-glycero-3-phospho-1D-myo-inositol + a fatty acid + H+. In simpler terms, it is an enzymatic activity that cleaves a fatty acid from phosphatidylinositol, a key membrane phospholipid, producing lysophosphatidylinositol and a free fatty acid. This activity is synonymous with phosphatidylinositol lysophospholipase A1-type activity and belongs to the molecular function ontology.
Why Is phosphatidylinositol lysophospholipase A1 activity Important in Cell Biology?
GO:0120561 is important because it controls the levels of lysophosphatidylinositol (LPI), a bioactive lipid that regulates cell proliferation, migration, and survival [2,7]. LPI and related lysophospholipids are implicated in cancer progression, particularly malignant melanoma, where lipid signaling drives metastasis and chemo-resistance. Additionally, this activity modulates inflammatory responses through eicosanoid production, linking it to diseases such as arthritis and cardiovascular disorders. The enzyme(s) carrying this activity, such as the 85-kDa phospholipase A2, are regulated by phosphorylation and calcium, making them responsive to cellular signals. Therefore, understanding GO:0120561 offers insights into lipid-mediated pathology and potential therapeutic targets.
• Regulates lysophosphatidylinositol levels, which influence cell signaling and membrane dynamics.
• Contributes to eicosanoid production and inflammation.
• Implicated in malignant melanoma progression and metastasis.
• Modulates tumor angiogenesis and chemo-resistance via lipid signaling.
• Plays a role in neurological disorders through lysophospholipid metabolism in the brain.
• Enzyme activity is regulated by phosphorylation and calcium in macrophages.
• Yeast PLB1 is a model for studying lysophospholipase and phospholipase B activity.
• Autotaxin and lipid phosphate phosphatases regulate lysophosphatidate signaling, intersecting with this activity.
• Lysophosphatidate and sphingosine 1-phosphate regulate autotaxin expression, linking to broader lipid networks.
• Targeting this activity may offer therapeutic strategies for cancer and inflammatory diseases [2,3].
What Happens During phosphatidylinositol lysophospholipase A1 activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs phosphatidylinositol in the membrane.
The enzyme recognizes the inositol headgroup and the sn-1 acyl chain of phosphatidylinositol, positioning the substrate for hydrolysis. This specificity distinguishes it from other phospholipases that act on phosphatidylcholine or phosphatidylethanolamine.
Catalytic Hydrolysis
In simple terms: Water breaks the bond between the fatty acid and the glycerol backbone.
A water molecule attacks the ester bond at the sn-1 position, releasing a free fatty acid and forming lysophosphatidylinositol. This reaction requires a catalytic dyad or triad typical of serine hydrolases, as seen in the 85-kDa phospholipase A2.
Product Release and Signaling
In simple terms: The products leave the enzyme and can act as signals.
Lysophosphatidylinositol and the fatty acid are released into the membrane or extracellular space, where they can activate signaling pathways, including those involving autotaxin and lipid phosphate phosphatases. These products influence cell proliferation, migration, and survival.
Regulation by Phosphorylation and Calcium
In simple terms: The enzyme's activity can be turned on or off by chemical tags and calcium.
In macrophages, the 85-kDa phospholipase A2 lysophospholipase activity is regulated by phosphorylation and calcium, allowing rapid responses to inflammatory stimuli. This regulation ensures tight control of lipid mediator production.
Key Genes Involved in GO:0120561 phosphatidylinositol lysophospholipase A1 activity
The following genes and proteins are associated with phosphatidylinositol lysophospholipase A1 activity or related lipid signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLB1 (yeast) | Encodes a protein with lysophospholipase and phospholipase B activity | Model for studying phospholipase B and lysophospholipase functions |
| PLA2G4A (85-kDa cPLA2) | Exhibits lysophospholipase activity toward phosphatidylinositol | Regulated by phosphorylation and calcium in macrophages |
| ENPP2 (autotaxin) | Produces lysophosphatidate from lysophosphatidylcholine | Regulates lysophosphatidate signaling in tumor progression |
| LPAR1-6 | Lysophosphatidic acid receptors | Mediate downstream effects of lysophospholipid signaling |
| PLPP1-3 | Lipid phosphate phosphatases | Regulate lysophosphatidate levels and signaling |
| S1PR1-5 | Sphingosine 1-phosphate receptors | Cross-talk with lysophosphatidate signaling |
| SPHK1/2 | Sphingosine kinases | Produce sphingosine 1-phosphate, regulating autotaxin |
| GNA12/13 | G protein subunits | Mediate lysophosphatidic acid signaling |
| RHOA | Small GTPase | Downstream of lysophosphatidic acid signaling |
| MAPK1/3 | Mitogen-activated protein kinases | Transduce lipid signals to proliferation |
| PI3K/AKT | Phosphoinositide 3-kinase pathway | Survival signaling downstream of LPI |
| NFKB1 | Transcription factor | Inflammatory response to lipid mediators |
| PTGS2 (COX-2) | Prostaglandin synthase | Eicosanoid production linked to phospholipase activity |
| ALOX5 | Arachidonate 5-lipoxygenase | Leukotriene synthesis from fatty acids |
| CYP2J2 | Cytochrome P450 epoxygenase | Epoxyeicosatrienoic acid production |
| PLA2G6 | Calcium-independent phospholipase A2 | May exhibit lysophospholipase activity |
| LPCAT1-4 | Lysophosphatidylcholine acyltransferases | Remodel lysophospholipids |
| ABHD12 | Lysophosphatidylserine lipase | Related lysophospholipid metabolism |
How Is phosphatidylinositol lysophospholipase A1 activity Regulated?
The activity of enzymes exhibiting phosphatidylinositol lysophospholipase A1 activity is regulated at multiple levels. In macrophages, the 85-kDa phospholipase A2 lysophospholipase activity is activated by phosphorylation and calcium. Autotaxin expression and secretion are regulated by lysophosphatidate and sphingosine 1-phosphate, creating feedback loops that influence lysophospholipid signaling. Additionally, lipid phosphate phosphatases degrade lysophosphatidate, thereby modulating the duration and intensity of signaling. These regulatory mechanisms ensure that lysophospholipid levels are tightly controlled in normal physiology and become dysregulated in diseases such as cancer.
phosphatidylinositol lysophospholipase A1 activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ENPP2 (autotaxin) | Cancer progression, metastasis | Knockout melanoma cell lines and mouse xenografts |
| PLA2G4A | Inflammation, arthritis | Point mutation in catalytic domain in macrophages |
| PLB1 (yeast) | Fungal virulence, lipid metabolism | Knockout yeast strains for lysophospholipase assays |
| LPAR1 | Cancer, fibrosis | Overexpression in melanoma cells |
| PLPP1 | Cancer, chemo-resistance | Knock-in of phosphatase-dead mutant |
Malignant Melanoma
Lipid signaling, including lysophosphatidate and lysophosphatidylinositol pathways, promotes melanoma progression, angiogenesis, and metastasis. Elevated autotaxin and lysophosphatidate levels correlate with poor prognosis, and enzymes with lysophospholipase A1 activity may contribute to the production of these bioactive lipids.
Inflammation and Arthritis
Phospholipases, including lysophospholipases, are key players in eicosanoid production, which drives inflammatory responses. Dysregulated activity can lead to chronic inflammation and tissue damage, as seen in rheumatoid arthritis.
Neurological Disorders
Lysophospholipid metabolizing enzymes are present in the human brain, and their dysregulation may contribute to neurodegenerative conditions. The balance between lysophospholipids and their metabolites is critical for neuronal function.
Cardiovascular Disease
Myocardial phospholipases, including lysophospholipases, are involved in ischemic injury and arrhythmogenesis. Their activity can influence membrane integrity and lipid mediator release in the heart.
From phosphatidylinositol lysophospholipase A1 activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of phosphatidylinositol lysophospholipase A1 activity reduce LPI levels? | CRISPR knockout of candidate enzyme in cell lines |
| How does a point mutation in the catalytic serine affect enzyme activity? | CRISPR point mutation (e.g., S->A) in the enzyme gene |
| Can a tagged version of the enzyme reveal its subcellular localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression of the enzyme increase LPI and promote migration? | Overexpression via lentiviral transduction |
| What are the downstream signaling changes upon enzyme knockout? | RNA-seq and phosphoproteomics in knockout cells |
| Is the enzyme's lysophospholipase activity regulated by phosphorylation? | Phospho-mutant knock-in (e.g., S->A or S->D) |
How to Study the phosphatidylinositol lysophospholipase A1 activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | Phosphatidylinositol and lysophosphatidylinositol levels | Quantify enzyme activity in cells |
| In vitro enzyme assay | Lysophospholipase A1 activity | Characterize enzyme kinetics and inhibitors |
| CRISPR knockout screening | Gene essentiality and pathway interactions | Identify regulators of lipid signaling |
| RNA-seq | Transcriptional changes upon enzyme manipulation | Discover downstream pathways |
| Phosphoproteomics | Phosphorylation events regulated by the enzyme | Map signaling networks |
| Fluorescence microscopy | Subcellular localization of enzyme and lipids | Study membrane dynamics |
| Yeast genetics | Lysophospholipase and phospholipase B activity | Model enzyme function in a simple organism |
| Autotaxin activity assay | Lysophosphatidate production | Measure cross-talk with LPI pathway |
Lipidomic Profiling
Mass spectrometry-based lipidomics can quantify phosphatidylinositol and lysophosphatidylinositol levels in cells or tissues, directly measuring the products of GO:0120561 activity. This method is essential for validating enzyme function in knockout or overexpression models.
Enzymatic Activity Assays
In vitro assays using radiolabeled or fluorescent phosphatidylinositol substrates can measure lysophospholipase A1 activity in cell lysates or purified enzyme preparations. These assays are used to determine kinetic parameters and inhibitor sensitivity.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that regulate lysophosphatidylinositol levels or downstream signaling, uncovering novel components of the pathway. This approach is powerful for discovering synthetic lethal interactions in cancer cells.
Imaging and Subcellular Localization
Fluorescently tagged enzymes or lipid probes can visualize the subcellular distribution of phosphatidylinositol lysophospholipase A1 activity and its products. Live-cell imaging reveals dynamic changes in lipid signaling.
How CRISPR Can Be Used to Study GO:0120561 phosphatidylinositol lysophospholipase A1 activity
Knockout
CRISPR knockout of genes encoding phosphatidylinositol lysophospholipase A1 activity (e.g., PLA2G4A or PLB1) can abolish enzyme function, leading to altered lysophosphatidylinositol levels and downstream signaling [1,6]. These models are used to test the requirement of the enzyme in cancer cell proliferation and migration.
Point Mutation
Introducing point mutations in the catalytic domain (e.g., serine to alanine) via CRISPR can specifically inactivate the enzyme without affecting protein levels, allowing precise dissection of its catalytic role. Such models are valuable for distinguishing enzymatic from scaffolding functions.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous locus enables visualization and immunoprecipitation of the enzyme, revealing its interactome and subcellular localization. Knock-in of phospho-mimetic or phospho-dead mutations can probe regulation by phosphorylation.
Overexpression
CRISPR activation or lentiviral overexpression of the enzyme can elevate lysophosphatidylinositol levels, promoting phenotypes such as increased cell migration and survival. Overexpression models are useful for gain-of-function studies in melanoma and other cancers.
How EDITGENE Supports phosphatidylinositol lysophospholipase A1 activity Research
Researchers studying phosphatidylinositol lysophospholipase A1 activity-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, disease progression, or cellular metabolism. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes associated with GO:0120561.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol lysophospholipase A1 activity research.
Frequently Asked Questions About phosphatidylinositol lysophospholipase A1 activity
What is phosphatidylinositol lysophospholipase A1 activity?
It is an enzymatic activity (GO:0120561) that removes a fatty acid from phosphatidylinositol, producing lysophosphatidylinositol and a free fatty acid.
What genes are involved in phosphatidylinositol lysophospholipase A1 activity?
Genes such as PLA2G4A, PLB1, and ENPP2 encode enzymes with this or related activities [4,6,7].
What is the reaction catalyzed by GO:0120561?
The reaction is: 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = sn-glycero-3-phospho-1D-myo-inositol + a fatty acid + H+.
How is phosphatidylinositol lysophospholipase A1 activity regulated?
It can be regulated by phosphorylation and calcium, as shown for the 85-kDa phospholipase A2 in macrophages.
What diseases are associated with phosphatidylinositol lysophospholipase A1 activity?
It is implicated in malignant melanoma, inflammation, neurological disorders, and cardiovascular disease [1,2,3,5].
What is the role of lysophosphatidylinositol in cancer?
Lysophosphatidylinositol and related lysophospholipids promote cancer cell proliferation, migration, and survival, contributing to metastasis [2,7].
Which model organisms are used to study this activity?
Yeast (Saccharomyces cerevisiae) with PLB1 and mouse macrophages are common models [4,6].
How can CRISPR be used to study phosphatidylinositol lysophospholipase A1 activity?
CRISPR knockout, point mutation, knock-in, and overexpression can manipulate genes encoding this activity to test their function in cells [1,4,5].
What methods measure phosphatidylinositol lysophospholipase A1 activity?
Lipidomics, in vitro enzyme assays, and CRISPR screens are key methods [1,4,7].
Is phosphatidylinositol lysophospholipase A1 activity a drug target?
Yes, targeting this activity or its downstream signaling pathways is being explored for cancer and inflammatory diseases [2,3,7].
Conclusion
Phosphatidylinositol lysophospholipase A1 activity (GO:0120561) is a critical enzymatic function that regulates lysophosphatidylinositol levels and lipid signaling. Its roles in cancer, inflammation, and neurological disorders make it a compelling subject for mechanistic and therapeutic research [2,3,5]. By leveraging CRISPR-based models and advanced lipidomics, researchers can dissect the causal contributions of specific genes to disease. EDITGENE provides the tools and expertise to accelerate these discoveries.
References
- 1. Weglicki WB et al.. 1987. Phospholipases of the myocardium.. Basic Res Cardiol 82 Suppl 1:107-12 PMID: 3310998
- 2. Tímár J et al.. 2018. The role of lipid signaling in the progression of malignant melanoma.. Cancer Metastasis Rev 37(2-3):245-255 PMID: 29808460
- 3. Famaey JP. 1982. Phospholipases, eicosanoid production and inflammation.. Clin Rheumatol 1(2):84-94 PMID: 6821386
- 4. de Carvalho MG et al.. 1995. Regulation of lysophospholipase activity of the 85-kDa phospholipase A2 and activation in mouse peritoneal macrophages.. J Biol Chem 270(35):20439-46 PMID: 7657619
- 5. Ross BM et al.. 1994. Characterization of lysophospholipid metabolizing enzymes in human brain.. J Neurochem 63(5):1839-48 PMID: 7931340
- 6. Lee KS et al.. 1994. The Saccharomyces cerevisiae PLB1 gene encodes a protein required for lysophospholipase and phospholipase B activity.. J Biol Chem 269(31):19725-30 PMID: 8051052
- 7. Samadi N et al.. 2011. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.. Biochimie 93(1):61-70 PMID: 20709140
- 8. Benesch MG et al.. 2015. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.. J Lipid Res 56(6):1134-44 PMID: 25896349
